Naturalistic Study to Evaluate the Utilization of Care Services Associated to the Diagnostic Process of Any Kind of Epilepsy
NCT00522522 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 400
Last updated 2012-05-30
Summary
Naturalistic, multicentre, epidemiological study to evaluate the care services used during the process of diagnosis of any kind of epilepsy. Data about services since first seizure until confirmed diagnosis will be examined.
Conditions
Sponsors & Collaborators
-
UCB Pharma
lead INDUSTRY
Principal Investigators
-
UCB Clinical Trial Call Center · +1 877 822 9493 (UCB)
Eligibility
- Min Age
- 16 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-02-29
- Primary Completion
- 2008-07-31
- Completion
- 2008-07-31
Countries
- United States
Study Locations
More Related Trials
-
Human Epilepsy Project 2: Resistant Focal Seizures Study
NCT03531008 ·Status: COMPLETED
-
Evaluation and Treatment of Patients With Epilepsy
NCT00013845 ·Status: TERMINATED
-
An Observational Study of Epilepsy: Biology and Outcomes Using Real-world Data
NCT05632978 ·Status: RECRUITING
-
NYU Epilepsy Self-Management Study
NCT07087821 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Study to Evaluate the Efficacy and Safety of Seletracetam in Adult Patients With Refractory Partial Onset Seizures
NCT00422110 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
Determine Safety and Efficacy of Long-term Oral Lacosamide in Patients With Partial Seizures
NCT00522275 ·Status: COMPLETED ·Phase: PHASE3
-
Open-Label Extension Study to Assess the Safety and Seizure Frequency Associated With Lacosamide for Primary Generalized Tonic-Clonic Seizures in Subjects With Epilepsy
NCT01118962 ·Status: COMPLETED ·Phase: PHASE2
-
Epilepsy Prevalence and Intervention Study in Zhejiang Province, China
NCT04944641 ·Status: UNKNOWN ·Phase: NA
-
To Determine Tolerability and Efficacy of Long-term Oral Lacosamide in Patients With Partial Seizures
NCT00552305 ·Status: COMPLETED ·Phase: PHASE2
-
Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures
NCT01191086 ·Status: COMPLETED ·Phase: PHASE3
-
Cognitive Enhancement Intervention for Creating a Healthy L.I.F.E (Lifestyle Interventions for Epilepsy)
NCT05954182 ·Status: RECRUITING ·Phase: NA
-
A Long-term Safety and Tolerability Study of USL261 in Patients With Seizure Clusters
NCT02161185 ·Status: TERMINATED ·Phase: PHASE3
-
Research Study to Test Safety and Effectiveness of Investigational Drug in Patients With Trigeminal Neuralgia
NCT00203229 ·Status: COMPLETED ·Phase: NA
-
Human Epilepsy Project 3
NCT05374928 ·Status: ACTIVE_NOT_RECRUITING
-
Managing Epilepsy Well- WebEase Project
NCT00726076 ·Status: COMPLETED ·Phase: NA
-
Cortical Resections in Drug Resistant Epilepsy
NCT04553354 ·Status: UNKNOWN
-
A Study of UCB0942 in Adult Patients With Highly Drug-resistant Focal Epilepsy
NCT02495844 ·Status: COMPLETED ·Phase: PHASE2
-
To Evaluate the Long-Term Safety of Pregabalin in Refractory Partial Epilepsy.
NCT00141414 ·Status: COMPLETED ·Phase: PHASE2
-
Study Of The Safety And Efficacy Of Lyrica In The Treatment Of Newly Diagnosed Partial Epilepsy
NCT00280059 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of BGG492 as Adjunctive Treatment in Patients With Partial Onset Seizures
NCT01147003 ·Status: COMPLETED ·Phase: PHASE2
-
Epilepsy-Associated Stigma
NCT01374204 ·Status: COMPLETED
-
Assessment of Suicidality in Epilepsy - Rating Tools
NCT01085461 ·Status: COMPLETED
-
A Study to Investigate Dosage, Effectiveness, and Safety of Perampanel When Used as First Add-on Therapy in Participants >=12 Years With Partial Onset Seizures With or Without Secondary Generalization or With Primary Generalized Tonic-Clonic Seizures Associated With Idiopathic Generalized Epilepsy
NCT04252846 ·Status: COMPLETED
-
A Study to Investigate How Effective, Safe and Tolerable the Drug NBI-921352 is When Used With Anti-seizure Medications in Adults With Focal Onset Seizures
NCT05159908 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Investigate LP352 in Subjects With Developmental and Epileptic Encephalopathies
NCT05364021 ·Status: COMPLETED ·Phase: PHASE1/PHASE2